Skip to main content
. 2021 Dec 21;10(2):e257–e268. doi: 10.1016/S2214-109X(21)00497-6

Table 1.

Baseline demographic and anthropometric characteristics in all participants vaccinated during the campaign

Needle and syringe (n=917) Disposable syringe jet injector (n=929) Intradermal adapter (n=874) Total (n=2720)
Age (months)
4–23 months 316 (34·5%) 331 (35·6%) 323 (37·0%) 970 (35·7%)
24–59 months 601 (65·5%) 598 (64·4%) 551 (63·0%) 1750 (64·3%)
Mean (SD) 31·9 (15·8) 31·0 (15·7) 30·4 (15·8) 31·1 (15·7)
Sex
Female 456 (49·7%) 460 (49·5%) 438 (50·1%) 1354 (49·8%)
Male 461 (50·3%) 469 (50·5%) 436 (49·9%) 1366 (50·2%)
Ethnic group
Mandinka 355 (38·7%) 470 (50·6%) 450 (51·5%) 1275 (46·9%)
Jola 266 (29·0%) 251 (27·0%) 208 (23·8%) 725 (26·7%)
Other 296 (32·3%) 208 (22·4%) 216 (24·7%) 720 (26·5%)
Maternal schooling
No school 449 (49·0%) 394 (42·4%) 404 (46·2%) 1247 (45·8%)
1–9 years: lower or upper basic 316 (34·5%) 302 (32·5%) 297 (34·0%) 915 (33·6%)
>9 years: secondary or college 152 (16·6%) 233 (25·1%) 173 (19·8%) 558 (20·5%)
Maternal occupation
At-home housewife 732 (79·8%) 664 (71·5%) 563 (64·4%) 1959 (72·0%)
Small trader or non-skilled worker 115 (12·5%) 189 (20·3%) 248 (28·4%) 552 (20·3%)
Professional and other 70 (7·6%) 76 (8·2%) 63 (7·2%) 209 (7·7%)
Height for age Z score <–2SD 204 (22·2%) 194 (20·9%) 147 (16·8%) 545 (20·0%)
Weight for height Z score <–2SD 60 (6·5%) 80 (8·6%) 56 (6·4%) 196 (7·2%)
Previous number of oral poliovirus vaccine doses, median (IQR) 6·0 (5·0–7·0) 6·0 (5·0–7·0) 6·0 (5·0–7·0) 6·0 (5·0–7·0)

Data presented as n (%) unless otherwise stated.